Meridian Financial Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $290K | Buy |
1,564
+1
| +0.1% | +$185 | 0.14% | 89 |
|
2025
Q1 | $327K | Sell |
1,563
-160
| -9% | -$33.5K | 0.17% | 83 |
|
2024
Q4 | $306K | Hold |
1,723
| – | – | 0.16% | 80 |
|
2024
Q3 | $340K | Sell |
1,723
-36
| -2% | -$7.1K | 0.17% | 79 |
|
2024
Q2 | $301K | Hold |
1,759
| – | – | 0.18% | 69 |
|
2024
Q1 | $286K | Buy |
1,759
+40
| +2% | +$6.5K | 0.37% | 34 |
|
2023
Q4 | $281K | Buy |
+1,719
| New | +$281K | 0.29% | 43 |
|
2023
Q2 | – | Sell |
-1,325
| Closed | -$211K | – | 87 |
|
2023
Q1 | $211K | Sell |
1,325
-4,330
| -77% | -$690K | 0.24% | 44 |
|
2022
Q4 | $841K | Sell |
5,655
-6
| -0.1% | -$892 | 0.95% | 27 |
|
2022
Q3 | $809K | Buy |
5,661
+389
| +7% | +$55.6K | 1.15% | 23 |
|
2022
Q2 | $797K | Buy |
5,272
+151
| +3% | +$22.8K | 0.54% | 47 |
|
2022
Q1 | $830K | Buy |
5,121
+76
| +2% | +$12.3K | 1.24% | 23 |
|
2021
Q4 | $682K | Buy |
+5,045
| New | +$682K | 0.46% | 46 |
|